Abstract
Lipoprotein-associated phospholipase A(2)(Lp-PLA(2)) is a biomarker that can be used to assess the risk for cardiovascular disease and events. In addition to being a useful marker of a risk factor, several studies suggest that Lp-PLA(2) has a pathophysiologic role in the atherosclerotic disease process. In this article, we review this aspect and its therapeutic implications.
MeSH terms
-
1-Alkyl-2-acetylglycerophosphocholine Esterase / analysis
-
1-Alkyl-2-acetylglycerophosphocholine Esterase / drug effects
-
1-Alkyl-2-acetylglycerophosphocholine Esterase / physiology*
-
Acute Coronary Syndrome / enzymology
-
Atherosclerosis / diagnosis
-
Atherosclerosis / enzymology*
-
Biomarkers / analysis
-
Coronary Disease / enzymology
-
Endothelial Cells / physiology
-
Humans
-
Hypolipidemic Agents / pharmacology
-
Prognosis
-
Risk Factors
-
Stroke / enzymology
Substances
-
Biomarkers
-
Hypolipidemic Agents
-
1-Alkyl-2-acetylglycerophosphocholine Esterase